Range Energy {CSE: RGO} major shareholder GULF LNG has confirmed an increase in shareholding in the company.

Gulf now own 65.4% of the company.

2015-11-09 16:53 ET – News Release

GULF LNG INCREASES HOLDINGS OF RANGE SHARES

Further to the news release of Range Energy Resources Inc. dated Nov. 9, 2015, announcing the company’s closing of the third tranche of a non-brokered private placement of 10,727,500 units, with each unit consisting of one common share and one share purchase warrant, Gulf LNG America LLC purchased 8,227,500 of the units issued in the private placement. The units were purchased by Gulf for four cents per unit, for a total purchase price of approximately $329,100.

As a result of the private placement, Gulf owns 432,450,272 common shares of the company, representing 65.4 per cent of the company’s issued and outstanding common shares. In addition, Gulf has the right to acquire an additional 302,050,272 common shares pursuant to the 8,227,500 share purchase warrants issued to it in the private placement, as well as the 29.75 million, 6,545,500, 17.8 million, 30 million, 20 million, 20 million, 25 million, 22,727,272 and 122 million share purchase warrants that Gulf had previously purchased in October, 2015, August, 2015, July, 2015, November, 2014, October, 2014, July, 2014, June, 2014, May, 2014, and November, 2013, respectively.

If Gulf fully exercised such share purchase warrants, it would own 734,500,544 common shares, which would represent 76.25 per cent of the company’s then issued and outstanding common shares. Immediately prior to the private placement, Gulf held 424,222,772 common shares of the company, representing 65.22 per cent of the company’s then issued and outstanding common shares.

Gulf acquired the securities for investment purposes and intends to evaluate its investment and to increase or decrease its holdings in the company as circumstances warrant.

The units were issued to Gulf in reliance upon the registration and prospectus exemptions in Section 2.3 of National Instrument 45-106, Prospectus and Registration Exemptions.

Christmas is approaching, and thoughts turn to the London Mining Week, of which the Mines and Money show at Islington used to be the highlight.

Update since publication

UPDATE

Since publishing the article below, I have now received acceptance to attend the show!

Whether it was down to this article I don;t know, but it is interesting that I submitted my application at exactly the same time as my friend, and he received his acceptance within hours, mine has taken many weeks!

Anyway, good that they have relented, I hope they allow everyone with an interest in mining into the show, a fully inclusive show is a vibrant show, and the mining sector needs all the friends it can get at the moment!

PDAC is a great show because it invites all comers, Mines and Money hopefully has learned this, and will become the major European mining event.

——-

As a regular attendee at the London Mines and Money show, and a long term investor in mining companies, I was incredibly disappointed to be told last year that to attend my home mining show, I would have to pay a £1,400 admission fee!

Needless to say I politely declined their kind and generous invitation to pay the equivalent of a weeks trip to Toronto to attend the PDAC, which is by far and away the world’s biggest and best mining show!

In particular I was disappointed because originally the show was for institutional professionals, but after an email inquiry from myself, private and retail investors were allowed to attend the show. In those days the staff listened and engaged with people, now they refuse to reply to lucid emails and hide behind a veil of secrecy.

The end result is that companies that pay to attend expecting to meet investors are being denied access to some investors, and you have to ask the question why?

The show is devaluing itself, whereas all the other shows around the world welcome investors with open arms, particularly now! yet London deters investor attendance!  Well done chaps!

I sincerely doubt any investor asked to pay the £1,400 will actually pay it, and so fewer people will attend and therefore there will be fewer opportunities for the participating companies to engage with and meet potential investors in their stock.

I personally attend shows in various countries each year, and am made very welcome everywhere, except my home city, and they won’t give me a reason, what a farce!

Quite what Mines and Money think they are gaining from alienating London based investors is beyond me, anyone holding stock in any of the participating companies, especially those from overseas, should email those companies and request a meeting outside, due to their exclusion from the show.

Perhaps once this is more widely known, Mines and Money may make their show fully inclusive, and restore it to its former glory?

But I won’t be holding my breath……….

A poor week for the mining sector has been concluded by the sad news of the Brazilian tailings disaster, where two tailings ponds at an iron ore mine  belonging to BHP – VALE burst, flooding the surrounding area and sadly, resulting in around 20 deaths in a nearby town.

The mining sector had another poor week, culminating with the the price of gold falling due to the anticipated US interest rate rise in December, as a result of the favourable US job numbers.

As if this wasn’t bad enough for the mining sector, news then emanated  from Brazil that the Samarco iron ore mine belonging to BHP  and VALE had suffered a serious tailings dam breach, releasing a tidal wave of sludge and water that had deluged local towns, and resulted in the deaths and disappearance of “dozens” of people.

The cause of the breach is not known at this stage, but localised earth tremors just before the breach are being suggested as a possible cause.

With the news of a US interest rate rise being a more or less slam dunk in December forcing down the price of gold, the news of the Brazilian disaster was the last thing the mining sector needed.

Inovio Pharmaceuticals {NASDAQ: INO} drug  INO-3112 Shows Robust Immune responses in patients with head and neck cancer

2015-11-05 08:00 ET – News Release

PLYMOUTH MEETING, Pa., Nov. 05, 2015 — Inovio Pharmaceuticals, {NASDAQ:INO} announced today an interim data analysis showing that its INO-3112 DNA-based immunotherapy generated specific T-cell responses and was well tolerated in all evaluable patients with head and neck cancer associated with human papillomavirus (HPV) types 16 and 18.

The immunology results show that INO-3112 generated robust HPV16/18 specific CD8+ T cell responses and antibodies against HPV16/18 in all 10 tested patients who received all treatments. These results will be presented today and tomorrow at the 30^th Anniversary Annual Meeting of the Society for Immunotherapy of Cancer in National Harbor, MD and on Nov 20-22 at the European Society for Medical Oncology Symposium on Immuno-Oncology in Lausanne, Switzerland.

INO-3112, an active immunotherapy targeting HPV 16/18 combined with a DNA plasmid for IL-12 as an immune activator, is designed to activate patient’s immune responses to specifically kill HPV associated tumors. In this phase I/IIa study, patients with HPV positive head and neck cancer received INO-3112 once every three weeks for a total of four injections.

The characteristics of these immune response data mirror those previously observed in a phase II clinical study of VGX-3100 for HPV-associated cervical dysplasia. In that study, strong CD8+ T cell immune responses were positively correlated with achievement of primary and secondary efficacy endpoints. Data from that trial was recently published in a peer-reviewed article in The Lancet. This publication details that VGX-3100 is the first therapy to demonstrate that activated killer T cells induced in the body have the power to clear neoplastic lesions as well as the virus which caused the disease.

Dr. Charu Aggarwal, MD, MPH, Assistant Professor of Medicine, Medical Oncologist at Abramson Cancer Center, University of Pennsylvania, Philadelphia and the principal investigator of this study said, “These results are in line with our hypothesis that DNA immunotherapy would lead to activation of the immune system. We are excited to follow these patients and learn about long-term results with this immunotherapy.”

Dr. J. Joseph Kim, Inovio’s President and CEO, said, “These results demonstrate we’re on the right path using our DNA immunotherapies to fight cancer. In immuno-oncology, it’s all about the T cells. Here we show in cancer patients that we can generate antigen-specific CD8+ killer T cell responses, which are essential to an effective immunotherapy.”

This open label study is intended to assess the safety, tolerability, and immunogenicity of INO-3112 in up to twenty five adults with HPV-positive head and neck squamous cell carcinoma. The study (NCT02163057) includes patients who are being treated with INO-3112 before and after resection of their tumor as well as patients being treated with INO-3112 after completion of chemotherapy and radiation therapy. This study currently continues patient enrollment at Abramson Cancer Center of University of Pennsylvania in Philadelphia. In August 2015, Inovio licensed INO-3112 to MedImmune, the global biologics research and development arm of AstraZeneca, for an upfront payment of $27.5 million, $700 million in potential development and commercial milestone payments, and royalties on INO-3112 product sales.

About HPV-Caused Head & Neck Cancer

Human papillomavirus (HPV) is the most common sexually transmitted disease in the United States, infecting 79 million Americans. HPV is known to play a major role in the development of head and neck cancers, which include cancers of the oral cavity, oropharynx, nose/nasal passages and larynx. Head and neck cancers associated with HPV account for nearly 3 percent of all cancers in the United States and are twice as prevalent in men as in women. Incidence rates of HPV-caused head and neck cancers have been on the rise, especially HPV-associated oropharyngeal cancer in men, and are expected to continue growing. By 2025, researchers believe that HPV will be the causative factor of 90% of all head and neck cancers.

About Inovio Pharmaceuticals, Inc.

Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that is generating T cells, in vivo, in high quantity that are fully functional whose killing capacity correlates with relevant clinical outcomes with a favorable safety profile. With an expanding portfolio of immunotherapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include MedImmune, Roche, University of Pennsylvania, DARPA, GeneOne Life Science, Drexel University, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and University of Manitoba.

For more information, visit www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines, our expectations regarding our research and development programs and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, including safety and efficacy for VGX-3100, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, our ability to support our broad pipeline of SynCon® active immune therapy and vaccine products, our ability to advance our portfolio of immune-oncology products independently, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, our ability to enter into partnerships in conjunction with our research and development programs, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company’s technology by potential corporate or other partners or collaborators, capital market conditions, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2014, our Form 10-Q for the quarter ended June 30, 2015, and other regulatory filings from time to time. There can be no assurance that any product in Inovio’s pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.

CONTACT:                                                                                                                            
Investors:
Bernie Hertel
Inovio Pharmaceuticals
+1 858-410-3101
bhertel@inovio.com

Neometals {ASX: NMT} has issued its quarterly activities report for the period ended 30th September 2015.

ASX Release 29 October 2015

QUARTERLY ACTIVITIES REPORT For the quarter ended 30 September 2015 Highlights:

Mt Marion Lithium Project.

• Construction of Mt Marion Lithium concentrate operation commences following positive Final Investment Decision and financial completion of Offtake and Equity Investment by Jiangxi Ganfeng Lithium Co. Ltd, China’s second largest lithium producer.Neometals received US$19.75M, with Mt Marion project equity decreasing to 45%.
• First production of lithium concentrate expected mid-2016.
• Project development including Mine-to-Port solution fully funded by Mineral Resources Ltd on a Build-Own-Operate basis.
• New Mineral Resource Estimate increases contained lithium by 60%. Barrambie Titanium Project
• Pre-feasibility Study confirms technical feasibility and financial viability of a licenced proprietary process to produce +99% pure titanium dioxide (TiO2).
• Potential lowest quartile operating cost per tonne of pure TiO2 produced after by-product credits. Pre-tax NPV12% US$355 million.

• Corporate
• Cash and restricted access term deposits $34 million.
• Ongoing evaluation of opportunities to divestment nickel portfolio.

PROJECT LOCATIONSMT MARION LITHIUM PROJECT

(Neometals 45%, Mineral Resources Limited 30%, Jiangxi Ganfeng Lithium Co. 25%)

During the quarter, the Company and Mineral Resources Limited {ASX: MIN} announced the start of the construction phase of the Mt Marion Lithium Project following the Final Investment Decision.

Mt Marion is a globally significant lithium deposit, containing total Indicated and Inferred Mineral Resources of 23.24Mt at 1.39% Li2O and 1.43% Fe2O3, at a cut-off grade of 0% Li2O (Appendix B). The project has a granted Mining Proposal and received its Works Approval for plant construction, on the 18th of December 2014.

First production is expected by mid-2016 from the Project, which is designed to produce more than 200,000tpa of chemical grade spodumene concentrate.

Project Offtake and Equity Investment

On 28 September the Company announced financial completion of the Share Sale, Subscription and Option Agreement, and life-of-mine Offtake Agreement with Jiangxi Ganfeng Lithium Co., Ltd.

Neometals received a net amount of US$19.75 million from Ganfeng in respect to the equity investment in RIM.

A Mining Services Agreement with MIN for the construction and operation of the Project on a Build- Own-Operate basis.

A summary of the key terms of the agreements are set out on the next page.

Share Sale, Subscription and Option Agreement

Following financial close, the shareholdings in RIM are as follows:

• Neometals – 45% PMI – 30%
• Ganfeng – 25%

Neometals has also granted PMI and Ganfeng options pursuant to which they can elect to increase their respective shareholdings in RIM by around Q4 of 2016 by acquiring shares from Neometals at an agreed price. If these options are fully exercised, Neometals will be left holding 13.8% of RIM and PMI and Ganfeng will each hold 43.1%.

Offtake Agreement

Ganfeng will purchase 100% of spodumene production from the Mount Marion Lithium Project for the life of the mine (‘LOM’) at market prices on a CIF basis, subject to an agreed floor.

After the first three years of production, MIN/Neometals can exercise options to collectively purchase up to 51% of spodumene production, with Ganfeng purchasing the remaining production.

Mining Services Agreement

MIN (via its wholly owned subsidiary, Process Minerals International Pty Ltd) will build, own and operate the mining, crushing and beneficiation infrastructure and equipment for the Mount Marion Lithium Project.

New Mineral Resource Estimate

A new Mineral Resource Estimate has increased Indicated and Inferred Mineral Resources to 23.24Mt at 1.39% Li2O and 1.43% Fe2O3, at a cut-off grade of 0% Li2O (Table 1 and Appendix A), compared to 14.8Mt at 1.3% Li2O, at a cut-off grade of 0.3% Li2O previously. This represents a substantial increase in the size of the mineral resource, equating to a 60% increase in the total contained lithium at the Project. The zero cut-off grade reflects the strategy of mining to the lithium- bearing pegmatite contacts. A grade-tonnage curve is included for transparenc

Avalon rare Metals {TSX: AVL} has published an update on its tin project at East Kemptville in Nova Scotia, Canada.

AVL have also conformed the results of their PEA will be known by 30th November 2015.

Toronto, Ontario– November 3, 2015) –  Avalon Rare Metals {TSX: AVL} is pleased to provide the following update on the $1.3 million 2015 work program on the East Kemptville Tin-Indium project, Yarmouth Co., Nova Scotia.

This program includes diamond drilling on the three known mineralised zones, metallurgical process testwork and preliminary environmental assessment studies. The environmental and metallurgical work will be incorporated (along with the October, 2014 resource estimate) in a Preliminary Economic Assessment (“PEA”) scheduled for completion before November 30, 2015.

The current drilling program is designed to collect additional metallurgical sample material from the previously-mined Main and Baby Zones and test other known mineralized zones including the Duck Pond deposit to delineate additional economic resources for a feasibility study. An updated resource estimate will be prepared in early 2016 once all the results from the 2015 drilling have been received and compiled.

The site access agreement with the surface rights holder has been further extended until November 30, 2015 to provide sufficient time to complete the 2015 work program. In the meantime, discussions continue towards reaching an agreement to transition full title to the property to Avalon. The parties expect to be able to conclude an agreement by year-end 2015.

2015 Drill Program

The 2015 drill program commenced on July 13^th and to date seventeen drill holes have been completed for a total of 3,301 metres. This includes 8 holes on the Baby Zone, 4 holes on the Main Zone and 5 holes on the Duck Pond Zone. Costs are coming in under budget which will allow for at least 4 more drill holes in the program, focused on the northeast extension of the Main Zone, before the program is concluded later this month. Proposed drilling on the South Grid Zone has been deferred until 2016.

The assays for the eight holes drilled on the Baby Zone have been received and compiled. Results are in line with expectations and confirm continuity of the mineralized zone to depth. Highlights include intersections of 0.46% tin (Sn), 25.2 ppm indium (In) and 0.63% zinc (Zn) over 82.3 metres (EKAV-15-10), 0.23% Sn, 15.6 ppm In and 0.33% Zn over 36.25 metres (EKAV-15-09) and 0.25% Sn, 29.4 ppm In and 0.64% Zn over 18.67 metres (EKAV-15-11).¹

A summary of significant intercepts is presented in Table 1 and the detailed drill hole locations are provided in Table 2. The drilling on the Baby Zone has successfully recovered about one tonne of sample for metallurgical testwork purposes and increased the confidence level of the Baby Zone resources.

In addition, certain sections of 2014 drill core that were not sampled last year due to apparent low levels of visible mineralization were sampled and submitted for assay this summer. These produced some surprising results indicating significant widths of mineralization adjacent to existing known mineralized intervals (Table 3). The intercepts given in Table 3 are examples located outside the boundaries of the existing October, 2014 resource estimate that, in effect, have potential to increase the total near surface resource estimate in the Baby Zone.

Metallurgical Testwork Program

The comprehensive bench scale metallurgical test work currently being undertaken in the UK is nearing completion. This extensive test program is evaluating the metallurgical flowsheet from grinding, through copper and zinc sulphide flotation, to tin recovery by both gravity and flotation methods. The recovery of indium to the zinc concentrate is also being measured as microprobe data of the zinc ore mineral sphalerite shows very high levels of contained indium (up to 0.25%) . Some metallurgical test results are still outstanding but preliminary analysis of the data suggests that the recoveries and grades for all three concentrates are in line with expectations.

PEA Report Preparation

Avalon has retained the services of Micon International Limited Toronto, Ontario to prepare a NI 43-101 compliant PEA for the East Kemptville project. The PEA will be based upon the existing NI 43-101 resource estimate (disclosed in the Company’s news release dated October 31, 2014), together with the final results from the metallurgical testwork program and environmental input provided by Stantec Consulting Limited Halifax, Nova Scotia (“Stantec”). Work on the PEA is progressing well and is on schedule for completion by the end of November 2015.

Environmental Assessment Work

Stantec’s Halifax office has considerable experience with the East Kemptville site and is conducting the key studies required as part of the Environmental and Social Impact Assessment for the permitting process and a planned feasibility study. Through the innovative use of low permeability tailings disposal technology, processing of the low grade ore stockpiles and engineered oxygen barriers (water covers), a cost effective tailing and waste rock management strategy has been developed. This strategy has the potential to greatly reduce the risk from existing acid-generating waste rock and tailings at the site and could result in a site closure plan that will eliminate the need for expensive perpetual water treatment.

Update on Tin Markets

Avalon recently joined the UK-based International Tin Research Institute (“ITRI”), which is dedicated to supporting the global tin industry and expanding tin use while providing its members with frequent updates on new developments in global tin markets. For further information, please visit the ITRI website at https://www.itri.co.uk/. Recent ITRI market commentary highlights the need for new tin mines to be developed to replace steadily declining production capacity from existing mines in Peru, Indonesia and China. This is creating opportunities for emerging new tin producers.

Unlike the major base metals, little new tin production capacity has come on-stream over the past 10 years during the commodities super-cycle. While LME tin prices have come down to the US$15,000/tonne level in 2015 from over $20,000/tonne in 2014, LME tin inventories remain low and many industry analysts believe that tin prices will rise in the absence of significant new supply. Also, some tin supplies originating in Central Africa are now designated as conflict minerals which preclude their use by consumers in the US and EU under legislation restricting the use of minerals produced to finance armed conflict. The overall conclusion is that new supplies from non-conflict sources, such as Nova Scotia, will be needed over the next five years just to meet continuing demand from the electronics sector.

Avalon will be presenting during the upcoming ITRI London Tin Seminar on November 26 at 11:30am GMT at the Brewery, Chiswell Street, London, England. For further information on this event or to register, please contact Lesley.Lewis@itri.co.uk.

The technical information included in this news release has been reviewed and approved by the Company’s Vice President Exploration, Dr. Bill Mercer, P. Geo, who is a Qualified Person under NI 43-101.

For questions or feedback, please email the Company at ir@avalonraremetals.com

or phone

Don Bubar, President & CEO, at +1 416 364 4938.

¹   All widths are drilled widths. True Widths are not known.

Cautionary Statement

This news release contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements regarding the commencement and completion of its work programs, that environmental and metallurgical work will be incorporated in a PEA scheduled for completion before November 30, 2015, that an updated resource estimate will be prepared in early 2016, that Avalon and the surface rights holder expect to be able to conclude an agreement by year-end 2015, that the Company’s strategy has the potential to greatly reduce the risk from existing acid-generating waste rock and tailings at the site and may result in a site closure plan that will eliminate the need for expensive perpetual water treatment, that many industry analysts believe that tin prices will rise in the absence of significant new supply and that new supplies from non-conflict sources such as Nova Scotia will be needed over the next five years just to meet continuing demand from the electronics sector . Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “potential”, “scheduled”, “anticipates”, “continues”, “expects” or “does not expect”, “is expected”, “scheduled”, “targeted”, “planned”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be” or “will not be” taken, reached or result, “will occur” or “be achieved”. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Avalon to be materially different from those expressed or implied by such forward-looking statements. Forward-looking statements are based on assumptions management believes to be reasonable at the time such statements are made. Although Avalon has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. Factors that may cause actual results to differ materially from expected results described in forward-looking statements include, but are not limited to market conditions, the possibility of cost overruns or unanticipated costs and expenses, and unanticipated results from the work programs, as well as those risk factors set out in the Company’s current Annual Information Form, Management’s Discussion and Analysis and other disclosure documents available under the Company’s profile at www.SEDAR.com. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Such forward-looking statements have been provided for the purpose of assisting investors in understanding the Company’s plans and objectives and may not be appropriate for other purposes. Accordingly, readers should not place undue reliance on forward-looking statements. Avalon does not undertake to update any forward-looking statements that are contained herein, except in accordance with applicable securities laws.

Cautionary Note to U.S. Investors Concerning Estimates of Reserves and Resources

Unless otherwise indicated, all reserve and resource estimates and other technical information included in this press release have been prepared in accordance with NI 43-101. NI 43-101 is a rule developed by the Canadian Securities Administrators which establishes standards for all public disclosure an issuer makes of scientific and technical information concerning mineral projects.

Canadian standards for disclosure of information, including NI 43-101, differ significantly from the requirements of the United States Securities and Exchange Commission (the “SEC”), and reserve and resource information contained in this press release may not be comparable to similar information disclosed by United States companies. In particular, and without limiting the generality of the foregoing, the term “resource” does not equate to the term “reserve”. Under United States standards, mineralization may not be classified as a “reserve” unless the determination has been made that the mineralization could be economically and legally produced or extracted at the time the reserve determination is made. The SEC’s disclosure standards normally do not permit the inclusion of information concerning “measured mineral resources”, “indicated mineral resources” or “inferred mineral resources” or other descriptions of the amount of mineral in mineral deposits that do not constitute “reserves” by United States standards in documents filed with the SEC. The requirements of NI 43-101 for identification of “reserves” are also not the same as those of the SEC, and reserves reported by Avalon in compliance with NI 43-101 may not qualify as “reserves” under SEC standards. Accordingly, information concerning mineral deposits set forth herein may not be comparable with information made public by companies that report in accordance with United States standards.

TABLE 1: Mineralized intercepts, 2015 drilling, Baby Zone, East Kemptville

*Indicates preliminary results subject to further QA/QC verification

TABLE 2: Drill Hole locations

TABLE 3: New significant mineralized intercepts from 2014 drill core sampled and assayed in 2015

Nymox Pharma {NASDAQ: NYMX} reports results of prospective cross-over study for prostrate cancer treatment.

The trial of fexapotide triflutate for low grade localized prostate cancer has shown statistical significance in efficacy compared to controls.

Nymox Reports Results of Prospective Cross-Over Study of Fexapotide Treatment for Prostate Cancer

2015-10-29 10:31 ET – News Release

HASBROUCK HEIGHTS, N.J.,- Nymox Pharmaceutical Corp. {NASDAQ: NYMX} reported today that long-term randomized cross-over data from the Company’s  trial of fexapotide triflutate for low grade localized prostate cancer has shown statistical significance in efficacy compared to controls. The study results indicate that randomized control subjects who subsequently switched to fexapotide had long-term outcomes significantly superior to control patients who did not change (cross-over) to fexapotide treatment.

These results are the initial 18 month follow-up results for the fexapotide trial for prostate cancer to be reported. The cross-over study arm of NX03-0040 consisted of 35 subjects. Based on biopsy progression the proportion of patients who progressed on biopsy and required biopsy progression-related surgery or radiotherapy in the cross-over group (0%) at 18 months was significantly less than in the control group (p<.03).

The cross-over group patients received randomized fexapotide 15 mg or 2.5 mg in a single treatment targeted toward the positive baseline cancer focus identified in initial positive biopsies. There were no cases in either of the 2 fexapotide dosage level treatment groups with biopsy progression at 18 months (p<.03).

In addition to the positive clinical progression results, the primary endpoint of the study (re-biopsy absence of tumor in the initially positive biopsy baseline area of the prostate) also reached statistical significance (p<.03) in the cross-over study. At the 18 month assessments, the post-treatment biopsy taken from the treated area of the prostate which was initially positive at baseline, showed absence of tumor (tumor presence in re-biopsy of baseline positive focus n=0) in the cross-over treated patients, which was statistically significant compared to controls (p<.03).

The Company expects to report results from its long-term NX03-0040 low grade localized prostate cancer study in the fourth quarter.

One of the major problems with current prostate treatments for localized prostate cancer (radical prostatectomy, external beam radiation, or brachytherapy) is the relatively high incidence of reported sexual dysfunction post-treatment. In 9 studies, NX-1207 treatment has been shown to have no significant adverse effect post-treatment on sexual function or testosterone levels.

For more information please contact info@nymox.com

Forward Looking Statements

To the extent that statements contained in this press release are not descriptions of historical facts regarding Nymox, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the need for new options to treat BPH and prostate cancer, the potential of fexapotide to treat BPH and prostate cancer and the estimated timing of further developments for fexapotide. Such forward-looking statements involve substantial risks and uncertainties that could cause our clinical development program, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in the clinical drug development process, including the regulatory approval process, the timing of Nymox’s regulatory filings, Nymox’s substantial dependence on fexapotide, Nymox’s commercialization plans and efforts and other matters that could affect the availability or commercial potential of fexapotide. Nymox undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Nymox in general, see Nymox’s current and future reports filed with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F for the year ended December 31, 2014, and its Quarterly Reports.

Contact:
Paul Averback
Nymox Pharmaceutical Corporation

www.nymox.com

© 2015 Canjex Publishing Ltd. All rights reserved.

City Investors Circle are pleased to confirm the date for the next evening investor forum has been conformed as Wednesday 25th November 2015,at 18.00 for 18.30.

The full details and participants will be released shortly.

Range Energy {CSE: RGO} has announced a private placement at 4 cents a unit to existing large holder Harrington Global.

As a result, Harrington will hold shares and warrants of 16.38% of the company.

Range Energy investor Harrington buys 16 million units

2015-10-29 17:22 ET – News Release

HARRINGTON GLOBAL LIMITED ACQUIRES SECURITIES OF RANGE ENERGY RESOURCES INC.

Harrington Global Ltd., on behalf of Harrington Global Opportunities Fund Sarl, which it manages and advises, today acquired a total of 16,403,750 units of Range Energy Resources Inc. {CSE: RGO} at a price of four cents per unit on a private placement basis. Each unit consists of one common share and one common share purchase warrant of Range. Each warrant will entitle the holder thereof to purchase one share at a price of five cents at any time before Oct. 29, 2020.

Prior to the acquisition, the fund owned 76,433,000 shares. As a result of the acquisition, the fund beneficially owns, and Harrington exercises control and direction over, a total of 92,836,750 shares and 16,403,750 warrants, representing approximately 16.38 per cent of the issued and outstanding shares of 650,468,816 as confirmed by Range, calculated on a partially diluted basis.

The securities of Range were acquired in the ordinary course of business, for investment purposes only. Depending on market conditions and other factors, Harrington, on behalf of the fund, may from time to time acquire additional securities of Range, or continue to hold or dispose of some or all of the securities of Range in the open market, by private agreement or otherwise.

This news release is issued pursuant to National Instrument 62-103, the early warning system, and related takeover bid and insider reporting issues, which requires a report to be filed on SEDAR containing additional information with respect to the foregoing matters.

Former Barkerville Gold {TSX.V: BGM} CEO Frank Callaghan has reached a deal with the BCSC over the reporting of resources at the Barkerville project in 2012.

Former CEO Callaghan had agreed a one year ban on being an officer or director of a public company,and received a $30,000 fine.

Comment

Whilst the damage to shareholder value here was substantial, it is quite incredible that Barkerville Mines have committed to pay the fine,  as disclosed in the final paragraph of this report.

It’s a double whammy for shareholders, they lost in the fall after the report and stock suspension, and are now losing again as the company seems committed to paying this fine for their former CEO.

This does not send the right message to those effected, nor those watching from a market perspective.,in my opinion.

BCSC reaches deal with Callaghan

2015-10-27

The B.C. Securities Commission has imposed a one-year ban and a $30,000 fine on Frank Callaghan for violating the rules surrounding the reporting of resource estimates.

The breach occurred when he reported a massive 10.6-million-ounce indicated resource at Barkerville Gold Mines Ltd.’s {TSX.V: BGM} Cow Mountain project. The company later had to reduce that estimate to 1.04 million ounces.

The sanctions against Mr. Callaghan are contained in an order and agreed statement of facts the BCSC released on Tuesday, Oct. 27. The order bars Mr. Callaghan from serving as an officer or director of any public company and from engaging in investor relations for one year. He must also complete a course on the requirements of National Instrument 43-101, the rules governing the reporting of mineral resource estimates.

News of the  investigation is contained in a tiny snippet found deep in Barkerville’s annual financial results, filed on Thursday, June 25. In the notes to those statements (on page 41 of 50) the company discloses that it will reimburse its former CEO for “all the ongoing legal fees related to BCSC claims against the former CEO.”

Range Energy {CSE: RGO} says that their partner on the Shewashan Field in Kurdistan  has spudded the Shewashan 2 Development well.

Upon completion, the well will be put into production.

2015-10-26 – News Release

Mr. Toufic Chahine reports

SHEWASHAN-2 DEVELOPMENT WELL SPUDDED UNDER KHALAKAN FIELD DEVELOPMENT PLAN

On Oct. 8, 2015, Range Energy Resources Inc.’s {CSE: RGO} Gas Plus Khalakan (GPK), the sole contractor of the Khalakan block in the Kurdistan region of Iraq, issued a press release stating that it spudded the Shewashan-2 development well on Oct. 1, 2015, under phase 1 of the approved field development plan (FDP) for the Shewashan oil field in the Kurdistan region of Iraq.

The press release says that Shewashan-2 is expected to reach a total depth of approximately 3,000 metres in the Cretaceous Qamchuga reservoir, and take 120 days to drill and complete. The press release concludes by saying that once finished the well will be put into production and contribute to the phase 1 production target of 10,000 barrels of oil per day (bopd) in 2016.

The press release can be found at the New African Global Energy website.

The company is a 24.95-per-cent indirect shareholder of GPK through its ownership of 49.9 per cent of the shares of New Age Alzarooni 2 Ltd. (NAAZ2). NAAZ2 owns 50 per cent of the shares of GPK.

Range has no additional information on the extent of the discovery or the field development plan.

We seek Safe Harbor.

Scorpio Gold Corp. {TSX.V: SGN} have released further good drill results from their Brodie satellite deposit at Mineral Ridge, Nevada, USA.

This continues the trend of good drill results throughout 2015.

Vancouver, October 26, 2015 – Scorpio Gold Corp. {TSX.V: SGN} reports additional results from the 2015 expansion drilling program on the NW Brodie trend at its 70% owned Mineral Ridge project, located in Nevada.

Exploration drilling along the NW Brodie trend in 2015 continues to outline a semi-continuous mineralised corridor up to 300 meters wide that extends over a 500 meter strike length between the Brodie and Bluelite deposits. This area lies well outside of currently defined resources and modeled pit outlines. The Company’s management believes that results to date are promising and may potentially allow for building a new resource in this area.

Highlights from this latest phase of the 2015 drilling program on the NW Brodie trend include:

• MR151623: 3.81 grams per tonne (“g/t”) gold over 3.05 meters
• MR151634: 1.11 g/t gold over 4.57 meters
• MR151635: 1.04 g/t gold over 7.62 meters
• MR151636: 1.23 g/t gold over 9.14 meters
• MR151637: 1.16 g/t gold over 3.05 meters
• MR151661: 4.07 g/t gold over 18.29 meters
• MR151752: 4.87 g/t gold over 4.57 meters
• MR151754: 2.54 g/t gold over 6.10 meters
• MR151756: 3.98 g/t gold over 6.10 meters

About Scorpio Gold

Scorpio Gold holds a 70% interest in the producing Mineral Ridge gold mining Scorpio Gold holds a 70% interest in the producing Mineral Ridge gold mining operation located in Esmeralda County, Nevada with joint venture partner Elevon LLC (30%). Mineral Ridge is a conventional open pit mining and heap leach operation.

The Mineral Ridge property is host to multiple gold-bearing structures, veins and lenses at exploration, development and production stages. Scorpio Gold also holds a 100% interest in the advanced exploration-stage Goldwedge property in Manhattan, Nevada, with a fully permitted underground mine and 400 ton per day mill facility. The Goldwedge mill facility has been placed on a care and maintenance basis and can be restarted immediately when needed.

Scorpio Gold’s President & CEO, Peter J. Hawley, PGeo,, is a Qualified Person as defined by National Instrument 43-101 and has reviewed and approved the content of this release.

ON BEHALF OF THE BOARD
SCORPIO GOLD CORPORATION

Peter J. Hawley,
President & CEO

For further information contact:
Peter J. Hawley, CEO
Email: phawley@scorpiogold.com

Kootenay Silver {TSX.V: KTN} have once again extended the expiry of 3,930,000 warrants issued in 2012 for another twelve months beyond their expiry date of October 2015.

The terms of the warrants, and their original  price at $1.30, remain unchanged.

VANCOUVER, Oct. 23, 2015

Kootenay Silver Inc. {TSX.V: KTN} announces that it has, subject to regulatory approval, amended the expiry date of an aggregate total of 3,930,000 unexercised share purchase warrants.

Pursuant to the non-brokered unit private placement announced on October 4, 2012, a total of 3,430,000 share purchase warrants expiring on October 25, 2014 and 500,000 share purchase warrants expiring on October 30, 2014, were issued on October 25, 2012 and October 30, 2012 respectively. On October 10, 2014, expiration of both sets of warrants was extended by an additional 12 months, to October 26 and 30, 2015 respectively.

Subject to TSX Venture Exchange approval, the expiry date of the warrants will be extended for an additional twelve months, with 3,430,000 share purchase warrants expiring on October 25, 2016 and 500,000 share purchase warrants expiring on October 31, 2016. In all other respects, the terms of the warrants will remain unchanged and in full force and effect with the exercise price per warrant remaining unchanged at $1.30.

ABOUT KOOTENAY

Kootenay Silver Inc. is an exploration company actively engaged in the discovery and development of mineral projects in the Sierra Madre Region of Mexico and in British Columbia, Canada.

The Company’s top priority is the advancement of precious metals projects contained within its Promontorio Mineral Belt in Sonora, Mexico. This includes its La Negra high-grade silver discovery and its Promontorio Silver Resource. Kootenay’s core objective is to develop near term discoveries and long-term sustainable growth. Management comprises proven professionals with extensive international experience in all aspects of mineral exploration, operations and venture capital markets. Multiple, ongoing J/V partnerships in Mexico and Canada maximize potential for additional new discoveries while maintaining minimal share dilution.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements: The information in this news release has been prepared as at October 21, 2015. Certain statements in this news release, referred to herein as “forward-looking statements”, constitute “forward-looking statements” under the provisions of Canadian provincial securities laws. These statements can be identified by the use of words such as “expected”, “may”, “will” or similar terms.

Forward-looking statements are necessarily based upon a number of factors and assumptions that, while considered reasonable by Kootenay as of the date of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Many factors, known and unknown, could cause actual results to be materially different from those expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as otherwise required by law, Kootenay expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Kootenay’s expectations or any change in events, conditions or circumstances on which any such statement is based.

Source –  Kootenay Silver Inc.

Contacts;
James McDonald - CEO and President
+1 403 238 6986

Ken Berry - Chairman
+1 604 601 5652

www.kootenaysilver.com

Kootenay Silver {TSX.V: KTN} announced positive results and recovery rates from testing work at La Negra.

Management are delighted with the silver recovery grades.

Kootenay Reports Positive Results and High Recovery Rates from Preliminary Metallurgical Work Conducted on La Negra

VANCOUVER, Oct. 22, 2015 – Kootenay Silver Inc. {TSX.V: KTN.V} is pleased to report that it has received positive results from preliminary metallurgy tests conducted on samples from the Company’s 100% owned La Negra silver discovery in Sonora, Mexico. The purpose of the metallurgy program was to determine whether silver at La Negra is recoverable by commonly used extraction methods after crushing and grinding the material and to get an indication of what recovery rates might be expected.

Test results showed high silver recoveries by both leach extraction and flotation methods. Silver extraction in seven bottle roll tests (leach tests) ranged from 71 to 90%. Silver extraction in three rougher flotation tests ranged from 85 to 98%. Importantly, silver extraction by leaching was not influenced by sulphide sulphur content, and a sample of material from 100 to 200m below surface had 89% extraction in a bottle roll test. High silver recoveries by leaching, including in sulphide material, indicate potential for silver to be recovered on site in a dore, substantially reducing costs and discounts associated with a sulphide concentrate produced by flotation. Individual results are given in the tables at the end of the release.

States Kootenay President and CEO James McDonald, “We are very pleased to be able to report such excellent results from our initial metallurgical test work on La Negra. These preliminary results indicate that high silver recoveries should be achievable by simple, cost effective milling and extraction methods and they clearly reinforce La Negra’s potential to evolve into a low-cost, open pittable silver resource. This potential is further underscored by drill results to date on La Negra that have consistently returned multiple wide intersections of mineralization, starting at surface and remaining open along strike and to depth, at the kind of silver grades that are currently being mined by open pit methods in Mexico.”

Based on demonstrating favourable metallurgy on La Negra and because mineralization is open in three directions, Kootenay has revised its schedule and now plans to conduct a phase III drill program on La Negra to further delineate the extent of mineralization prior to completing a maiden NI 43-101 resource estimate. The Company will look to improve its balance sheet prior to drilling and is exploring different strategies to achieve its priorities, including equity, strategic partnerships or M&A.

Metallurgical test work was completed by Kappes Cassiday and Associates of Reno, Nevada, under the direction of Hans Smit, P.Geo, a Qualified Person as defined by NI 43-101. Seven samples were created for testing comprised of material from 9 or 10 sub-samples of drill core rejects from across the area drilled and grouped by specific vertical depth and grade ranges. Bottle roll leach tests were conducted on a 1,000 gram portion of each sample that was ring and puck pulverized to a target size of 80% passing 0.075 millimetres. Tests were run for a total of 96 hours, but in most tests the majority of the silver was recovered in the first 2 to 4 hours. Cyanide and lime inputs were not optimized.

La Negra – Bottle Roll Test Results

Portions of material from three samples were milled and utilized for flotation testing. Flotation tests were conducted using a laboratory-scale Denver flotation apparatus. The reagents utilized in the program were:

Copper Sulfate (CuSO4)
Potassium Amil Xanthate (PAX) (C3505)
MIBC (F 500)

Test results are only indicative of potential recovery values and reagent use and concentrate grades are not optimszed.

La Negra Silver Discovery

The La Negra Beccia prospect is situated approx. 7.0 kms north of Kootenay’s flagship Promontorio Silver Resource in Sonora, Mexico and is contained within a 25 x 15 km mineralized corridor, the ‘Promontorio Mineral Belt.’ La Negra was discovered in the fall of 2014 during the inaugural drill program, which followed surface trenching and sampling conducted early in 2014. Drilling in 2015 confirmed continuity of silver grades and widths setting the stage for advanced exploration of La Negra and reinforces its potential as a low cost, open pit silver resource (See news releases, ‘Drill Results’ Oct. 15, 2014, Nov. 26, 2014, Dec 3, 2014, March 31, 2015, April 30, 2015 and May 20, 2015 for more details).

To View Full Results of Sampling and mapping and Drilling Programs Visit: www.kootenaysilver.com

QA/QC

The foregoing geological disclosure has been reviewed and verified by Kootenay’s CEO, James McDonald, P.Geo (a qualified person for the purpose of National Instrument 43-101, Standards of Disclosure for Mineral Projects). Mr. McDonald is a director of Kootenay.

ABOUT KOOTENAY

Kootenay Silver Inc. is an exploration company actively engaged in the discovery and development of mineral projects in the Sierra Madre Region of Mexico and in British Columbia, Canada. The Company’s top priority is the advancement of precious metals projects contained within its Promontorio Mineral Belt in Sonora, Mexico. This includes its La Negra high-grade silver discovery and its Promontorio Silver Resource. Kootenay’s core objective is to develop near term discoveries and long-term sustainable growth. Management comprises proven professionals with extensive international experience in all aspects of mineral exploration, operations and venture capital markets. Multiple, ongoing J/V partnerships in Mexico and Canada maximize potential for additional new discoveries while maintaining minimal share dilution.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements: The information in this news release has been prepared as at October 21, 2015. Certain statements in this news release, referred to herein as “forward-looking statements”, constitute “forward-looking statements” under the provisions of Canadian provincial securities laws. These statements can be identified by the use of words such as “expected”, “may”, “will” or similar terms.

Forward-looking statements are necessarily based upon a number of factors and assumptions that, while considered reasonable by Kootenay as of the date of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Many factors, known and unknown, could cause actual results to be materially different from those expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as otherwise required by law, Kootenay expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Kootenay’s expectations or any change in events, conditions or circumstances on which any such statement is based.

Cautionary Note to US Investors: This news release may contain information about adjacent properties on which we have no right to explore or mine. We advise U.S. investors that the SEC’s mining guidelines strictly prohibit information of this type in documents filed with the SEC. U.S. investors are cautioned that mineral deposits on adjacent properties are not indicative of mineral deposits on our properties. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.

This press release uses the terms “Measured”, “Indicated”, and “Inferred” resources. United States investors are advised that while such terms are recognized and required by Canadian regulations, the United States Securities and Exchange Commission does not recognize them. “Inferred Mineral Resources” have a great amount of uncertainty as to their existence, and as to their economic and legal feasibility. It cannot be assumed that all or any part of an Inferred Mineral Resource will ever be upgraded to a higher category. Under Canadian rules, estimates of Inferred Mineral Resources may not form the basis of feasibility or other economic studies. United States investors are cautioned not to assume that all or any part of Measured or Indicated Mineral Resources will ever be converted into Mineral Reserves. United States investors are also cautioned not to assume that all or any part of a Mineral Resource is economically or legally mineable.

SOURCE Kootenay Silver Inc.
For further information:

James McDonald, CEO and President

+1 403-238 6986;

Ken Berry, Chairman

+1 604-601 5652

or visit: www.kootenaysilver.com

Cartier Resources {TSX.V: ECR} announced a closing of a private placement for $266,500.

This was a flow through placement done at a price of $0.13 per share.

VAL-D’OR, CANADA, Oct 22, 2015  —Cartier Resources Inc. {TSX>V: ECR} is pleased to announce the closing of a private placement.

The private placement is a flow-through private placement with accredited investors and consists of 205 units for an amount of $266,500.

For the flow-through private placement, each unit, at a price of $1,300 per unit, is comprised of 10,000 flow-through common shares at a price of $0.13 per share. Thus, the following securities were issued by Cartier, 2,050,000 flow-through shares at a price of $0.13 per share for an amount of $266,500.

The securities issued under the private placement are subject to a four (4) month and one (1) day statutory hold period.

The proceeds of the placement will be used by Cartier to conduct exploration on the Benoist, Cadillac Extension and MacCormack projects.

This press release is not an offer or a solicitation of an offer of securities for sale in the United States. The securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration.

Neither the TSX Venture Exchange nor its regulatory services provider accepts responsibility for the adequacy or accuracy of this press release.

Contact:
Philippe Cloutier, P.Geo.
President and CEO Cartier Resources Inc.
+1 819 856 0512
philippe.cloutier@ressourcescartier.com
www.ressourcescartier.com

SOURCE: Cartier Resources Inc.

Inovio {NASDAQ: INO} and their partner GeneOne Life Science of South Korea have filed an investigational new drug application with the FDA.

The objective is to move to phase 1 trial in healthy humans before the end of the year.

Inovio and Partner Advance MERS Vaccine

CONTACTS:                                                                                                                           
Investors:
Bernie Hertel,
Inovio Pharmaceuticals,
+1 858-410-3101,
bhertel@inovio.com

Colonial Coal {TSX.V: CAD} announced a financing to a major new investor at 10c per share (plus a half  warrant at 20c for two years), representing 19.86% of issued stock.

This is a huge vote of confidence in the assets and management team at Colonial. Drilling the highly prospective Flatbed property is now a priority, and positions Colonial amongst the very few exploration and development companies able to spend on exploration in these tough times.

Colonial Coal arranges $2.4-million private placement

2015-10-20 12:29 ET – News Release

Mr. David Austin reports.

PROPOSED PRIVATE PLACEMENT AND 10% FLATBED PROPERTY INTEREST ACQUISITION

Colonial Coal International Corp.{TSX.V: CAD} has recently entered into a letter agreement with a certain investor group which provides for the terms and conditions of each of a proposed private placement of units of the corporation together with the corresponding granting by the corporation to the investor of an option to acquire a 10-per-cent registered and beneficial ownership interest in the corporation’s Flatbed property, which will become available to the investor upon the successful completion of the private placement.

David Austin, the corporation’s president and chief executive officer, stated: “I am very pleased that we have been able to identify a potential long-term partner for the development of the company’s various property and business interests. We are hopeful that this partnership will continue to grow as Colonial Coal explores its many options going forward.”

Private placement

In conjunction with the proposed private placement, the corporation has agreed to offer up to 24 million units of the corporation, representing approximately 19.866 per cent of the presently issued and outstanding common shares of the corporation as of the date hereof on a non-diluted basis, to the investor at a price of 10 cents per unit for gross proceeds of up to $2.4-million. Each unit comprises one common share and one-half of one common share purchase warrant of the corporation, with each whole warrant entitling the investor to purchase an additional common share at an exercise price of 20 cents per common share for a period of two years from closing of the private placement. The private placement is expected to close in the next three weeks.

No finder’s fees will be payable by the corporation in connection with the completion of the private placement, and the corporation presently intends to utilize the proceeds of the private placement to initiate the first phase of the corporation’s planned and mutually agreed upon exploration program on its Flatbed property, and for general corporate and working capital purposes.

Closing of the private placement is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, inclusive of that of the TSX Venture Exchange. In accordance with the policies of the exchange, the corporation may be required to obtain disinterested shareholder approval to the investor becoming a control person (as defined by Policy 1.1 of the exchange) by virtue of any warrant exercise which would cause the investor to hold more than 20 per cent of the outstanding common shares. The corporation shall attend to obtaining disinterested shareholder approval as soon as reasonably practicable after the private placement closing.

Upon the successful completion of the entire private placement closing, however, subject at all times to any prior suitability and filing requirements of the exchange and all applicable securities laws and regulators, the investor will be entitled to the immediate appointment of one member to the corporation’s board of directors. In connection with such initial appointment, the corporation shall immediately grant to such initial appointee, in accordance with the provisions of the corporation’s current share option plan, as amended, a vesting (equally over 12 months) stock option to acquire up to two million common shares at an exercise price of 10 cents per common share for a period of five years from the date of such grant. In this respect, and in accordance with current exchange policy and the provisions of the corporation’s option plan, the initial option price may be subject to adjustment upwards at the time of the initial option grant so as to ensure that the initial option price represents the corporation’s current market trading price at the time.

All securities issued in connection with the private placement will be subject to a statutory hold period of four months plus one day from the date of issuance of the securities in accordance with applicable Canadian securities legislation.

Acquisition

Upon the successful completion of the entire private placement closing, the investor shall immediately acquire an option, exercisable within 90 calendar days of execution of the letter agreement, to acquire a 10-per-cent registered and beneficial ownership interest in those certain coal licenses that together comprise the Flatbed property located in the Liard mining division in northeastern British Columbia, Canada, for cash consideration of $5-million.

Pursuant to the terms and conditions of a proposed form of mineral property option agreement which is set forth in Schedule B thereto, it is acknowledged and agreed that the final form of acquisition agreement will be mutually agreed upon prior to the private placement closing. The acquisition is is expected to close before year-end.

Upon the successful completion of the acquisition closing, it is presently intended that the private placement and acquisition proceeds will be utilized by the corporation to complete the corporation’s planned and mutually agreed upon exploration program on its Flatbed property, and for general corporate and working capital purposes resulting therefrom.

Upon the successful completion of the acquisition closing, and in addition to the initial appointment and the initial option grant already provided for upon the successful completion of the entire private placement closing, however, subject at all times to any prior suitability and filing requirements of the exchange and all applicable securities laws and regulators, the investor will also be entitled to the immediate appointment of an additional member to the corporation’s board of directors with one member of the corporation’s then board of directors resigning. In connection with such additional appointment, the corporation shall immediately grant to such additional appointee, in accordance the provisions of the corporation’s option plan, a vesting (equally over 12 months) stock option to acquire up to two million common shares at an exercise price of 10 cents per common share for a period of five years from the date of such grant. In this respect, and again in accordance with current exchange policy and the provisions of the corporation’s option plan, the additional option price may be subject to adjustment upwards at the time of the additional option grant so as to ensure that the additional option price represents the corporation’s current market trading price at the time.

We seek Safe Harbor.

Condor Gold {AIM: CNR} has published the result of a study by Whittle Consulting in conjunction with SRK, which has optimised the potential for Condor to add ounces and andvance cashflow at their La India project, Nicaragua.

The study showed the possibility of increasing production by 22% in the first five years.

Israeli private company StoreDot has just received the accolade of Venture Capital Fund Globes “most promising startup company for 2015”.

This has come on the back of some promising developments in car battery rapid charging  technology.

StoreDot includes a large investment by Chelsea owner Roman Abramovich, amongst its small group of current shareholders.

StoreDot CEO Doron Myersdorf (left)

StoreDot sprang to fame on the back of their disruptive technology for recharging a Samsung S5 phone battery in 26 seconds from dead!

Now the company have shifted their focus to a car battery they claim will recharge from dead to fully charged in five minutes, (around the same time as it takes to fill a full tank of petrol), and have a 300 mile range.

The technology uses a molecular structure within the battery rather than lithium, and has the potential to disrupt current assumptions about future lithium demand, if they can perfect their technology, and deliver on performance.

Kootenay Silver {TSX.V: KTN} have optioned their Sonora, based copper gold Cervantes project to Aztec Metals of Mexico.

This is the third Kootenay non core  project to be optioned in the last year,as the company continues to generate projects whilst focusing on their main La Promontorio Silver asset.

KOOTENAY ANNOUNCES CERVANTES PROJECT OPTIONED TO AZTEC METALS

Kootenay Silver Inc. {TSX.V: KTN}  is pleased to announce that it has optioned its Cervantes Gold/Copper project located in Sonora, Mexico to Aztec Metals Corp.

Cervantes is a Gold/Copper Porphyry prospect located approximately 50 km northeast of the Company’s Promontorio Silver resource in Sonora, Mexico, which based on geologic observations, the Company believes has potential for hosting leachable gold resources. The project is the result of Kootenay’s generative program and was staked through its wholly owned Mexican subsidiary, Minera J.M.

States Kootenay President and CEO James McDonald, “We are very pleased to enter into an option agreement with Aztec Metals on our Cervantes Gold/Silver prospect in Sonora, Mexico. The agreement with Aztec represents our third successful option agreement in the past 12 months of our generative program. The agreement serves as a strong compliment to our previously announced option agreements over this same period, including optioning the Silver Fox property to the major copper mining company Antafogasta and the San Diego property to Alamos Gold. As we continue to advance our top priority La Negra silver discovery in Sonora, Mexico, our success finding and leveraging exciting new projects adds significantly to the intrinsic value in Kootenay, while providing maximum exposure to new discoveries and minimal share dilution through our generative program”.

The Cervantes Project

Previous work conducted by Kootenay shows the Cervantes concession to be underlain by a suite of mineralisation styles of which the California gold/copper porphyry is most significant. Important peripheral mineralized zones to the porphyry includes the sediment-hosted shear zone Brasil with polymetallic gold/silver, and low sulphidation epithermal veins and breccia’s. The mineralized systems are hosted within Paleozoic fine-grained clastics intruded by high level, quartz-eye porphyritic intrusions. Mineralisation is associated with major fault structures controlling a pull-apart basin.

The primary prospects within the Cervantes concession were discovered or identified as a result of Kootenay’s generative discovery program. All sampling results have been previously reported by Kootenay.

Brief descriptions of the principle mineralized zones follow and have been previously reported:

La Calfornia Gold/Copper Porphyry Prospect

A NE-trending keel-like stock measuring approximately 2 km long and between 200-500 metres wide. The porphyry system is divided into two parts: California East Au/Cu porphyry and the California West (Jasper Zone).

La California East

The porphyry is highly fractured and marked by intense stockwork veining and locally by breccia zones. Alteration is dominantly quartz, sericite, pyrite and locally silicic (stockwork quartz veining and silica flooding). Textures of limonites goethite, jarosite and hematite within the stockwork system are indicative of a leached cap and are strongly suggestive of secondary copper enrichment at depth.

Prospector sampling taken by Kootenay showed gold and copper assays taken within a 500 x 500 metre area that is coincident with argillic and sericitic alteration and leach-cap limonites. Ninety prospector and chip samples were taken. Fifty-eight samples gave values greater than 100 ppb (0.1gpt), with high values of 19.0, 9.8, 9.0, 5.1 and 4.4 gpt gold. The average value of gold from the porphyry and its immediate surroundings is 1.03 gpt gold (and 351 ppb or 0.35 gpt for all samples less than 2 gpt). Copper averages 554 ppm (0.05%), values consistent with published values from other supergene enriched porphyries in southwest USA. Visible secondary copper minerals (malachite) were noted only outside the leach-cap weathering zone.

The California East porphyry was subject to historic exploration drilling by Peñoles S.A.B. de C.V (“Peñoles”), who reportedly drilled 14 holes during 1996 and 1997. The only information recovered of this work is from third party reports and due to the lack of verifiable information, is not discussed.

California West Porphyry (Jasper Zone)

The extension of the main California East porphyry lies 300 metres to the west and is strongly sheared and argillized. Host rocks are comprised of quartz eye rhyolite porphyry and horrnfelsed Paleozoic dirty limestone/calcareous siltstones. Limited sampling (25 grab samples) gave values of gold from background to maximum values of 13.8, 1.85 and 0.68 gpt, silver up to 53 gpt and anomalous molybdenum (to 480 ppm). Copper (as secondary neotocite) and gold-silver mineralization are spatially associated with the porphyry Jasperoid and chalcedony occur both as replacement of country rock and pods of open-space infill’s that appear suggestive of a retrograde alteration on the edges of a porphyry system. A series of NW-trending resistant quartz-hematite strataform ribs crop out to the immediate west of the jasperoid zones.

Brasil Polymetallic Gold/Silver Prospect Area.

The Brasil prospect lies 1200 metres south of the California porphyry.. Gold-Silver-polymetallic mineralization within a 100 x 300m area is associated with a series of near bedding parallel shears with argillization and erratic quartz veining accompanied by strong goethite, jarosite and hematite. Individual mineralized shears are typically <1.5 metres thick, but the stacking of parallel shears over at least a 50 metre interval may provide a bulk-tonnage target. Thirty-two samples (mostly grab) have been collected over the Brasil area with 22 with values of gold greater than 0.1 gpt and 11 greater than 1 gpt including highs of 11.5, 6.2, 4.3, 3.6, and 3.0 gpt. A single 116 gpt silver assay was noted with 13 greater than 10 gpt. Anomalous copper, lead and zinc accompanies the precious metal mineralization. The Brasil prospect is controlled by the same structures controlling the California porphyry and is interpreted to represent a distal phase of the porphyry-style mineralisation.

Other Areas of Anomalous Mineraliation: Cervantes Concession

Cayo Norte: 400 metres north of the California East porphyry, reconnaissance exploration has noted epithermal silica veins and breccias hosting gold values from background to highs of 6.5, 6.4, 4.7, 4.2 and 1.4 gpt gold in grab samples.

Terms of the Agreement

The terms of the agreement allow Aztec to earn a 65% interest by spending an aggregate total US$1.5 million in exploration expenditures over 4 years (by July 25, 2019), to pay an aggregate total of US$150,000 in staged payments to the Company by July 25, 2019 and issue an aggregated total of 1,000,000 common shares of Aztec in staged payments on each anniversary with the final issuance payable 60 days after the fourth anniversary of July 25, 2019. Aztec will also be responsible for annual Mexican assessment work and mining concession taxes during the term of the agreement.

Upon earning the initial 65% interest and within 60 days of such date, Aztec will have the right to elect and acquire the remaining 35% interest by completing a preliminary economic assessment report (“Scoping Study”) by the fifth anniversary date (July 25, 2020), paying US$5.00 per gold or gold equivalent ounce of estimated recoverable, payable gold or gold equivalent ounce of the contained metal for the measured, indicated and inferred resources based on the Scoping Study. On acquisition by Aztec of 100% interest, Kootenay will receive a 2.5% net smelter royalty. If Aztec decide not to exercise the Second Option in order to acquire the remaining 35%, a joint venture will be formed to further develop the project. If at anytime during the process of exploration and/or development after the completion of the Scoping Study and before the completion of a feasibility study or production decision, an additional resource is delineated on the property Aztec shall have the right to acquire the remaining 35% interest under the same terms of acquiring the initial resource outlined previously.

The foregoing geological disclosure has been reviewed and verified by Kootenay’s CEO, James McDonald, P.Geo (a qualified person for the purpose of National Instrument 43-101, Standards of Disclosure for Mineral Projects). Mr. McDonald is a director of Kootenay.

ABOUT KOOTENAY

Kootenay Silver Inc. is an exploration company actively engaged in the discovery and development of mineral projects in the Sierra Madre Region of Mexico and in British Columbia, Canada. The Company’s top priority is the advancement of precious metals projects contained within its Promontorio Mineral Belt in Sonora, Mexico. This includes its La Negra high-grade silver discovery and its Promontorio Silver Resource. Kootenay’s core objective is to develop near term discoveries and long-term sustainable growth. Management comprises proven professionals with extensive international experience in all aspects of mineral exploration, operations and venture capital markets. Multiple, ongoing J/V partnerships in Mexico and Canada maximize potential for additional new discoveries while maintaining minimal share dilution.

For additional information, please contact:

James McDonald, CEO and President at +1 403 238 6986

Ken Berry, Chairman at +1 60 -601 5652

www.kootenaysilver.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements: The information in this news release has been prepared as at October 12, 2015. Certain statements in this news release, referred to herein as “forward-looking statements”, constitute “forward-looking statements” under the provisions of Canadian provincial securities laws. These statements can be identified by the use of words such as “expected”, “may”, “will” or similar terms.

Forward-looking statements are necessarily based upon a number of factors and assumptions that, while considered reasonable by Kootenay as of the date of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Many factors, known and unknown, could cause actual results to be materially different from those expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as otherwise required by law, Kootenay expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Kootenay’s expectations or any change in events, conditions or circumstances on which any such statement is based.

Cautionary Note to US Investors: This news release may contain information about adjacent properties on which we have no right to explore or mine. We advise U.S. investors that the SEC’s mining guidelines strictly prohibit information of this type in documents filed with the SEC. U.S. investors are cautioned that mineral deposits on adjacent properties are not indicative of mineral deposits on our properties. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.

This press release uses the terms “Measured”, “Indicated”, and “Inferred” resources. United States investors are advised that while such terms are recognized and required by Canadian regulations, the United States Securities and Exchange Commission does not recognize them. “Inferred Mineral Resources” have a great amount of uncertainty as to their existence, and as to their economic and legal feasibility. It cannot be assumed that all or any part of an Inferred Mineral Resource will ever be upgraded to a higher category. Under Canadian rules, estimates of Inferred Mineral Resources may not form the basis of feasibility or other economic studies. United States investors are cautioned not to assume that all or any part of Measured or Indicated Mineral Resources will ever be converted into Mineral Reserves. United States investors are also cautioned not to assume that all or any part of a Mineral Resource is economically or legally mineable.